PL2976102T3 - Szczepionka chroniąca przeżuwacze przed zapaleniem płuc wywołanym przez mannheimia haemolytica - Google Patents

Szczepionka chroniąca przeżuwacze przed zapaleniem płuc wywołanym przez mannheimia haemolytica

Info

Publication number
PL2976102T3
PL2976102T3 PL14710302T PL14710302T PL2976102T3 PL 2976102 T3 PL2976102 T3 PL 2976102T3 PL 14710302 T PL14710302 T PL 14710302T PL 14710302 T PL14710302 T PL 14710302T PL 2976102 T3 PL2976102 T3 PL 2976102T3
Authority
PL
Poland
Prior art keywords
vaccine
protect
mannheimia haemolytica
pneumonia caused
against pneumonia
Prior art date
Application number
PL14710302T
Other languages
English (en)
Inventor
Antonius Arnoldus Christiaan Jacobs
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47900898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2976102(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL2976102T3 publication Critical patent/PL2976102T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
PL14710302T 2013-03-18 2014-03-17 Szczepionka chroniąca przeżuwacze przed zapaleniem płuc wywołanym przez mannheimia haemolytica PL2976102T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13159665 2013-03-18
EP14710302.2A EP2976102B1 (en) 2013-03-18 2014-03-17 Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
PCT/EP2014/055244 WO2014147001A1 (en) 2013-03-18 2014-03-17 Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica

Publications (1)

Publication Number Publication Date
PL2976102T3 true PL2976102T3 (pl) 2020-05-18

Family

ID=47900898

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14710302T PL2976102T3 (pl) 2013-03-18 2014-03-17 Szczepionka chroniąca przeżuwacze przed zapaleniem płuc wywołanym przez mannheimia haemolytica

Country Status (8)

Country Link
US (1) US9642905B2 (pl)
EP (1) EP2976102B1 (pl)
AU (1) AU2014234452B2 (pl)
ES (1) ES2771473T3 (pl)
HU (1) HUE048344T2 (pl)
MX (1) MX357432B (pl)
PL (1) PL2976102T3 (pl)
WO (1) WO2014147001A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
CN115161211B (zh) * 2021-04-01 2023-07-14 金宇保灵生物药品有限公司 一种牛溶血性曼氏杆菌菌株及由其制备的灭活疫苗和疫苗制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132775A (en) * 1973-12-03 1979-01-02 Richardson-Merrell Inc. Infectious bovine rhinotracheitis virus vaccine and method of preparing and using the same
US5256415A (en) 1989-03-20 1993-10-26 Louisiana State University Vaccine against bovine respiratory disease (pasteurellosis)
EP0650734B1 (en) 1993-10-28 1999-03-10 Division Of Microbiology, Kyoto Biken Laboratories, Inc. Pentavalent live viral vaccine
EP0810283A3 (en) * 1996-05-31 1997-12-10 Akzo Nobel N.V. Live attenuated RTX-procucing bacteria of the family Pasteurellaceae
FI20002217A7 (fi) 1999-12-30 2001-07-01 Orion Yhtymae Oyj Inhalaatiopartikkelit
DE10152307A1 (de) 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
RS20050177A (sr) 2002-08-26 2007-06-04 Pfizer Products Inc., Vakcina za infekcije respiratornog i reproduktivnog sistema kod stoke
US6830010B2 (en) 2002-10-22 2004-12-14 Heartland Premium Beef, Inc. Quality assurance program and method for meat production
US8183026B2 (en) 2003-01-14 2012-05-22 Mississippi State University Methods of preparation of live attenuated bacterial vaccine by alteration of DNA adenine methylase (Dam) activity in those bacteria
EP1638598B1 (en) 2003-07-02 2006-12-06 Biotechnology Research And Development Corporation ACAPSULAR i P. MULTOCIDA HYAE /i DELETION MUTANTS
FR2862306B1 (fr) 2003-11-17 2008-05-30 Aventis Pasteur Composition vaccinale
US20080044440A1 (en) * 2004-02-18 2008-02-21 Margaret Dunkley Vaccine Formulated For Administration To Mucosa Of The Lungs
DE602005025404D1 (de) 2004-12-22 2011-01-27 Intervet Int Bv Impfstoff gegen pasteurella multocida
US20080241192A1 (en) 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica

Also Published As

Publication number Publication date
WO2014147001A1 (en) 2014-09-25
ES2771473T3 (es) 2020-07-06
AU2014234452B2 (en) 2018-02-22
US9642905B2 (en) 2017-05-09
AU2014234452A1 (en) 2015-09-10
MX357432B (es) 2018-07-09
US20160287690A1 (en) 2016-10-06
BR112015023870A2 (pt) 2017-07-18
EP2976102A1 (en) 2016-01-27
EP2976102B1 (en) 2019-12-11
HUE048344T2 (hu) 2020-08-28
MX2015013307A (es) 2016-01-25

Similar Documents

Publication Publication Date Title
IL276210B1 (en) Mers-cov vaccine
GB2520549B (en) Vacuum cleaner head
GB2517970B (en) A buffer
EP2970081A4 (en) SALTS OF TREPROSTINIL
SG11201509348XA (en) A propulsion system
GB201321242D0 (en) Immunogenic compound
SI3077047T1 (sl) Soli aramchola
HRP20181192T1 (hr) Spoj enzima za hidrolizirajuću biomasu
GB201301085D0 (en) Glycoconjugate Vaccine
GB2511500B (en) Improvements relating to pipelaying
GB2516136B (en) Colenterazine analogs
GB2541536B (en) Improvements to couplers
SG10201400878VA (en) Air Pipe Head
ZA201503804B (en) Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
HUE048344T2 (hu) Vakcina kérõdzõ védelmére Mannheimia haemolytica okozta tüdõgyulladás ellen
PL2958935T3 (pl) Szczepionka
PL2991675T3 (pl) Szczepionka Campylobacter
PL2911688T3 (pl) Szczepionki zapewniające ochronę krzyżową przeciwko salmonelli
GB201300324D0 (en) Improvements to letter-plates
GB2510111B (en) Vacuum cleaner head
GB201302134D0 (en) Improvements to a vacuum cleaner head
IL244246B (en) Multivalent sialic acid derivatives
GB201305967D0 (en) Improvements to a sight
GB201310038D0 (en) Position sensor suited to high velocity
GB201320646D0 (en) Vaccine